Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 658.62M P/E - EPS this Y 1.40% Ern Qtrly Grth -
Income -252.45M Forward P/E -2.74 EPS next Y -8.40% 50D Avg Chg -15.00%
Sales 10.6M PEG - EPS past 5Y - 200D Avg Chg -41.00%
Dividend N/A Price/Book 1.18 EPS next 5Y - 52W High Chg -64.00%
Recommedations 1.70 Quick Ratio 15.61 Shares Outstanding 118.22M 52W Low Chg 5.00%
Insider Own 4.88% ROA -18.20% Shares Float 90.74M Beta 0.89
Inst Own 97.18% ROE -28.36% Shares Shorted/Prior 11.98M/12.92M Price 9.30
Gross Margin - Profit Margin - Avg. Volume 1,032,227 Target Price 66.09
Oper. Margin -4,040.39% Earnings Date Nov 6 Volume 592,968 Change -2.31%
About Avidity Biosciences, Inc.

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat diseases previously untreatable with RNA therapeutics. The company's lead product candidate AOC 1001 for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease that is in phase 1/2 clinical trial. Its other products in pipeline include AOC 1044 for the treatment of duchenne muscular dystrophy, which is under phase 1/2 clinical development trial; and AOC 1020 to treat facioscapulohumeral muscular dystrophy that is in phase 1/2 clinical trial. The company is developing products for rare skeletal muscle and rare cardiac diseases. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.

Avidity Biosciences, Inc. News
11/14/24 Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study Data
11/14/24 RNA Stock Hits Record High on Entering the Cardiac Disease Space
11/13/24 Avidity Bio Has Surged 416% This Year โ€” And That's Before Today's 'Game-Changing' News
11/12/24 Avidity Biosciences Announces New Precision Cardiology Development Candidates to Treat Rare Genetic Cardiomyopathies and Provides First Look at Next-Generation Technology Innovations
11/09/24 Avidity Biosciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
11/07/24 Avidity Biosciences, Inc. (RNA) Reports Q3 Loss, Lags Revenue Estimates
11/07/24 Avidity Biosciences Reports Third Quarter 2024 Financial Results and Recent Highlights
11/06/24 Analysts Estimate Avidity Biosciences, Inc. (RNA) to Report a Decline in Earnings: What to Look Out for
11/06/24 An RNAi renaissance is creating a new generation of startups
10/31/24 Avidity Biosciences to Host Investor and Analyst Event Focused on Precision Cardiology Candidates and First Look at Next-Generation Technology Innovations on November 12, 2024
10/30/24 Avidity Biosciences Pursues Potential Accelerated Approval Path with Initiation of Biomarker Cohort in FORTITUDEโ„ข Trial for Delpacibart Braxlosiran (del-brax/AOC 1020) in People Living with Facioscapulohumeral Muscular Dystrophy
03:05 PM Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/18/24 Avidity Biosciences, Up 441%, Nears Another Record High As Dystrophy Space Heats Up
10/04/24 Why Avidity Biosciences Zoomed to a 12% Gain This Week
10/04/24 FDA lifts clinical hold on Avidityโ€™s lead antibody conjugate therapy trial
10/03/24 Avidity Biosciences Announces FDA Removed Partial Clinical Hold on Delpacibart Etedesiran (del-desiran/AOC 1001)
09/29/24 Is Avidity Biosciences, Inc. (RNA) the Best Performing Long Term Stock in 2024?
09/26/24 Is Avidity Biosciences Inc. (RNA) the Best Performing Small-Cap Stock in 2024?
09/25/24 Avidity Biosciences to Participate in Upcoming Investor Conference
09/05/24 Avidity Biosciences Joins Patient and Advocacy Communities in Raising Awareness During National Muscular Dystrophy Awareness Month
RNA Chatroom

User Image This_Bull_Is_Retired Posted - 2 hours ago

$RNA Is this one a BO Target? Price and volume are acting like it.

User Image Bugseason Posted - 1 day ago

@TammyM keep an eye on $SGMO $ALT $VKTX $ADAP $RNA

User Image swingingtech Posted - 2 days ago

$FNX $RNA $AVAV $LTH https://wallstreetwaves.com/analysts-anticipate-10-gains-ahead-for-fnx/

User Image Theflash88 Posted - 2 days ago

$RNA What happened?

User Image enz12 Posted - 4 days ago

$RNA chance to add here

User Image ChessGM Posted - 5 days ago

$RNA Top 10 stocks from RTW rtwfunds.com/ latest 13F report.

User Image stockpicker63 Posted - 5 days ago

๐ŸŒŸ Unstoppable Gains This Week! ๐ŸŒŸ Our system is riding the wave of excitementโ€”without even knowing why, it's celebrating our new president! ๐Ÿš€ Here are the weekโ€™s TOP TRADES that delivered outstanding results: ๐Ÿ“ˆ $ALT: +40% ๐Ÿ“ˆ $OUIST: +20% ๐Ÿ“ˆ $AXSM: +11% ๐Ÿ“ˆ $RNA: +11% ๐Ÿ“ˆ $BKSY: Pure Profit ๐Ÿ’ก Donโ€™t miss your chance to join the momentum and ride the trend. Trade smarter, win bigger. ๐Ÿ‘‰ Start your journey to success today! #ExtremeGains #TradingWins #successmindset

User Image enz12 Posted - 5 days ago

$RNA effing rfk effect ??๐Ÿ’ฉ

User Image ChartLaboratory_com Posted - 1 week ago

$MVST - "๐Ÿš€ #MVST up +340% and breaking major resistance at $1.05. Get ready for potential breakout with a target of $1.55. Watch volume closely! ๐Ÿ“ˆ #stockalert #breakout #daytrading #swingtrading #stocks" $RKLB - "๐Ÿ“Š Strong upward momentum for #RKLB (+28%) with support at $8.28. Watch for a breakout at $22.55 for potential gains. ๐Ÿ”ฅ #stockwatch #bullish #stocktrading #tradealerts #swingtrade" $RIVN - "๐Ÿ” #RIVN up +13.7%, testing key resistance at $13.22. Watch for breakout confirmation. Targeting $13.22 for further gains. ๐Ÿš€ #stocks #trading #breakout #stockmarket #investment" $DYN - "๐Ÿ“ˆ #DYN pushing upward (+16.3%) with strong support at $30.86. Look for a breakout at $35.68 and higher. ๐Ÿ’ฅ Target $47.45! #trading #stockalerts #swingtrading" $RNA - "๐Ÿš€ #RNA at $52.50 (+12.35%), testing upper Bollinger band at $56. Watch for breakout confirmation. Targeting $56 for next move. ๐Ÿ“Š #breakoutstocks #stocktrading"

User Image Doozio Posted - 1 week ago

$RNA INTA ๐Ÿง โฐโ™พ๏ธ

User Image enz12 Posted - 1 week ago

$RNA new regeneron .

User Image JFDI Posted - 1 week ago

$RNA big breakout. lunch hour pull in.

User Image thetechtrader Posted - 1 week ago

$RNA surged 7, flagged. Extension targets are 55 & 58. Support 50-50.50. #technicaltrading #daytrade #tradealert #marketrecap #stockstowatch #stockstobuy

User Image CDAinvestor Posted - 1 week ago

$RNA is on the move!

User Image MaverikIT Posted - 1 week ago

@IsabellaDC @net0trader @RonIsWrong $RNA

User Image skeezbag Posted - 1 week ago

$ARWR looks like the thorobread is $rna not $arwr

User Image BZAJDEL Posted - 1 week ago

$RNA This is going to have big announcements and great gains for years to come.

User Image Dombak Posted - 1 week ago

$RNA i've been in since February at $12.45. Still holding. What's driving the price action today?

User Image skiparock Posted - 1 week ago

$RNA so, how you doin

User Image Ohzipit Posted - 1 week ago

$RNA RJ page 2

User Image Ohzipit Posted - 1 week ago

$RNA RJ update remains strong buy. Page 1

User Image bachsong Posted - 1 week ago

$RNA ...watch BMY after RNA presentation ... IMO in good position to make offer

User Image NVDAMillionaire Posted - 1 week ago

$RNA Avidity Biosciences (NASDAQ:RNA) – Pioneering a New Class of RNA Therapeutics https://beyondspx.com/article/avidity-biosciences-nasdaq-rna-pioneering-a-new-class-of-rna-therapeutics

User Image enz12 Posted - 1 week ago

$RNA eoy over 60

User Image ahab Posted - 2 weeks ago

$CORT 48.06 10/23/24 3 red day price level, $RNA 45.42 3 red day price level, < WINNERS. $SRRK 3red day price level , down 2-3 % going stone age stock picking on this sector

User Image Bromberger Posted - 2 weeks ago

$RNA Time to break $50

User Image IN0V8 Posted - 10/31/24

$RNA Buy filled at $43

User Image Bugseason Posted - 10/28/24

$SGMO i had a dream sangamo reached 17.42 had the same dream with $RNA but at $48 and it hit a few times.

User Image CDAinvestor Posted - 10/24/24

$RNA is the next $MNPR

User Image insiderbuyingselling Posted - 10/23/24

$RNA new insider selling: 5000 shares. http://insiderbuyingselling.com/?t=RNA

Analyst Ratings
Goldman Sachs Buy Sep 24, 24
Cantor Fitzgerald Overweight Sep 18, 24
Cantor Fitzgerald Overweight Sep 16, 24
Cantor Fitzgerald Overweight Sep 9, 24
Barclays Overweight Aug 28, 24
Evercore ISI Group Outperform Aug 26, 24
Needham Buy Aug 13, 24
Evercore ISI Group Outperform Aug 12, 24
Chardan Capital Buy Aug 9, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
LEVIN ARTHUR A Director Director Jan 22 Sell 10.13 1,859 18,832 17,471 01/23/24
Boyce Sarah President and CEO President and CEO Jan 20 Sell 10.13 5,092 51,582 44,008 01/23/24
Flanagan W. Michael CSTO CSTO Jan 20 Sell 10.13 4,129 41,827 35,871 01/23/24
McCarthy Teresa Chief Human Resource.. Chief Human Resources Officer Jan 20 Sell 10.13 2,065 20,918 17,035 01/23/24
MacLean Michael F Chief Financial Offi.. Chief Financial Officer Jan 20 Sell 10.13 1,616 16,370 16,884 01/23/24
LEVIN ARTHUR A Chief Scientific Off.. Chief Scientific Officer Feb 14 Sell 23.93 10,000 239,300 19,330 02/15/23
LEVIN ARTHUR A Chief Scientific Off.. Chief Scientific Officer Feb 14 Option 1.24 10,000 12,400 29,330 02/15/23
Boyce Sarah President and CEO President and CEO Feb 01 Sell 24.3 50,000 1,215,000 53,352 02/03/23
Boyce Sarah President and CEO President and CEO Feb 01 Option 1.24 50,000 62,000 56,573 02/03/23
LEVIN ARTHUR A Chief Scientific Off.. Chief Scientific Officer Jan 12 Sell 22 10,000 220,000 1,330 01/17/23
LEVIN ARTHUR A Chief Scientific Off.. Chief Scientific Officer Jan 12 Option 1.24 10,000 12,400 11,330 01/17/23
LEVIN ARTHUR A Chief Scientific Off.. Chief Scientific Officer Dec 29 Sell 22.01 40,000 880,400 1,330 01/03/23
LEVIN ARTHUR A Chief Scientific Off.. Chief Scientific Officer Dec 29 Option 1.24 40,000 49,600 41,330 01/03/23
LEVIN ARTHUR A Chief Scientific Off.. Chief Scientific Officer Aug 12 Option 0.89 80,000 71,200 4,829 08/31/22
LEVIN ARTHUR A Chief Scientific Off.. Chief Scientific Officer Aug 12 Sell 22.07 80,000 1,765,600 1,330 08/31/22
Boyce Sarah President and CEO President and CEO Aug 24 Option 1.24 49,900 61,876 14,855 08/26/22
Boyce Sarah President and CEO President and CEO Aug 24 Sell 22.93 49,900 1,144,207 08/26/22
Boyce Sarah President and CEO President and CEO Aug 15 Option 1.24 100 124 100 08/17/22
Boyce Sarah President and CEO President and CEO Aug 15 Sell 22.47 100 2,247 08/17/22
LEVIN ARTHUR A Chief Scientific Off.. Chief Scientific Officer Jun 28 Option 1 20,200 20,200 21,430 06/28/21
LEVIN ARTHUR A Chief Scientific Off.. Chief Scientific Officer Jun 22 Option 1.24 200 248 1,530 06/22/21
LEVIN ARTHUR A Chief Scientific Off.. Chief Scientific Officer Jun 22 Sell 27.75 200 5,550 1,330 06/22/21
LEVIN ARTHUR A Chief Scientific Off.. Chief Scientific Officer Jun 16 Sell 25.97 37,022 961,461 06/16/21